Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In patients with pre-existing cardiovascular disease, optimization of cardiac medications may help mitigate heart rate increases
Chinas weight-loss drug makers take on global giants as Novo Nordisk patent expires Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
Approved products have product-specific labels, dosage forms, instructions, strengths, and uses
But emerging research suggests the medications offer impressive health benefits aside from lowering blood sugar levels and supporting weight loss
This was a 40-week study using the 12 mg dose
US$ 25.51
US$ 27.02
US$ 29.60
